Clinical Trial Update: A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated the safety of StromaForte, a human allogeneic bone-marrow-derived mesenchymal stromal cell product, for knee oste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• StromaForte (human allogeneic bone-marrow-derived mesenchymal stromal cells)

Snippet

Sponsor: Cellcolabs Clinical SPV Limited | Conditions: Osteo Arthritis Knee | Phase 1, Phase 2 | Status: COMPLETED